ovalbumin and tris(1-3-dichloro-2-propyl)phosphate

ovalbumin has been researched along with tris(1-3-dichloro-2-propyl)phosphate* in 1 studies

Other Studies

1 other study(ies) available for ovalbumin and tris(1-3-dichloro-2-propyl)phosphate

ArticleYear
Impact of dietary exposure to low-dose tris(1,3-dichloro-2-propyl)phosphate in allergic asthmatic mice.
    Immunopharmacology and immunotoxicology, 2021, Volume: 43, Issue:5

    Tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) is an organophosphorus flame retardant that is an alternative to brominated flame retardants. Although TDCIPP can adversely affect human health, information about its effects on immune and allergic responses is scarce. We aimed to investigate the effects of dietary exposure to TDCIPP using less than the human tolerable daily intake (TDI) in allergic asthmatic mice.. Male C3H/HeJSlc mice were fed a chow diet containing TDCIPP equivalent to 0.02 μg/kg/day (low; L), 0.2 μg/kg/day (medium; M), or 2 μg/kg/day (high; H) and were intratracheally administered ovalbumin (OVA, 1 μg/animal) every 2 weeks from 5 to 11 weeks of age.. In OVA-treated mice, TDCIPP-H exposure tended to enhance pulmonary inflammation compared with vehicle exposure. TDCIPP dose-dependently decreased mRNA level of G protein-coupled estrogen receptor (GPER) in the lungs with or without OVA. OVA + TDCIPP-H treatment tended to increase the total cell number and promoted CD4. These results suggested that dietary exposure to TDCIPP at TDI level slightly enhances allergic diseases, such as allergic asthma,

    Topics: Animals; Asthma; Cells, Cultured; Dietary Exposure; Flame Retardants; Lung; Male; Mice; Mice, Inbred C3H; Organophosphorus Compounds; Ovalbumin

2021